ABSTRACT
Accurate and objective histopathologic diagnoses of laryngeal precursor lesions remain a challenge.
1 H&E staining is the only available approach, but a considerable amount of disagreement can occur due to the subjectivity of pathologists, particularly interobserver discrepancies in the diagnosis of mild dysplasia and moderate dysplasia, which showed only 28.57% and 55.56% of concordance, respectively, among pathologists. [1] [2] [3] Furthermore, a retrospective survey reveals a significant difference in the risk of progression to laryngeal squamous cell carcinoma between mild dysplasia and moderate dysplasia. 4, 5 In 2017, the fourth edition of the World Health Organization (WHO) classification of head and neck tumors proposed a unified two-tiered classification consisting of low-grade dysplasia (including squamous hyperplasia and mild dysplasia) and high-grade dysplasia (including moderate dysplasia, severe dysplasia, and carcinoma in situ [CIS] ). For treatment purposes, the proposed two-tiered system can also be divided into a three-tiered classification with a differentiation between high-grade dysplasia and CIS. 6 This histologic grading system showed higher diagnostic consistency. 5, 6 In addition to H&E staining, we also need feasible and reliable biomarkers to support the new classification system. They are useful to credibly predict the biological behavior of laryngeal dysplasia and provide effective guidance on the treatment of patients.
Macrophages are generated from monocytes, which have remarkable plasticity that allows them to efficiently respond to environmental signals and change their phenotype. 7 One type of classically activated macrophages is M1-like macrophages, which can secrete proinflammatory cytokines and immune activation factors to promote inflammation and antitumor function. 8 The other is alternatively activated macrophages, named M2-like macrophages-also called tumor-associated macrophages (TAMs), which can promote carcinogenesis and the proliferation, invasion, and metastasis of tumor cells, as well as express high levels of scavenger receptor CD163. 9 Previous studies observed that the increased infiltration of TAMs was associated with metastasis and prognosis of laryngeal carcinoma. 10 Recently, a study reported that the increase of the CD163+ TAM infiltration rate was observed in mild and moderate epithelial dysplasia of oral premalignant lesions. 11 Highly infiltrated TAMs are associated with the progression of precancerous endometrial lesions. 12 Ki-67 and cyclin D1 are associated with an early change in premalignant epithelia 13, 14 ; in general, they represent the proliferation state of cells in almost all active phases of the cell cycle and play a role in carcinogenesis. However, the role of CD163+ TAMs during the occurrence and development of laryngeal precursor lesions remains unclear. The present study was initiated to evaluate the diagnostic value of CD163+ TAMs, Ki-67, and cyclin D1 to differentiate new different grades of laryngeal dysplasia in the 2017 WHO classification of head and neck tumors.
Materials and Methods

Specimen Collection
In total, 133 paraffin-embedded samples were collected from the Department of Pathology, Beijing Tongren Hospital, Capital Medical University between November 2009 and June 2011. For clinical treatment purposes, we apply the three-tiered classification, including low-grade laryngeal dysplasia (n = 31), high-grade laryngeal dysplasia (n = 49), CIS (n = 23), and 30 cases of normal mucosa. Laryngeal dysplasia cases were reviewed for histopathology grade using H&E staining by three experienced pathologists and examined according to the diagnostic criteria of laryngeal dysplasia. 6 This study was approved by the ethics committee of Beijing Tongren Hospital of Capital Medical University in Beijing, China.
Immunohistochemistry
First, 3-µm paraffin slides were deparaffinized in an incubator at 72°Cfor 30 minutes and then in xylene for 30 minutes. Then, slides were dehydrated with descending grades of alcohol wash (100% to 85%) for 5 minutes each. Slides were rinsed with phosphate-buffered saline (PBS).
Endogenous peroxidase activity was blocked in hydrogen peroxide (3%) for 10 minutes, and then the slides were rinsed with PBS. Antigen retrieval was completed by boiling slides in citrate buffer (10 nmol/L, pH 6) for 2.5 minutes in a pressure cooker at 120°C. The slides were left to cool at room temperature and rinsed with PBS. Then, the slides were incubated with primary antibody for Ki-67 (clone SP6, diluted 1:100; Abcam, Cambridge, UK), cyclin D1 (clone EP12, prediluted; Dako, Glostrup, Denmark), and CD163 (clone 10D6, prediluted; Abcam) in an incubator at 37°C for 30 minutes. After three rinse cycles with PBS, slides were incubated with biotinylated goat anti-mouse/rabbit secondary antibodies (ab6789/ab6721, diluted 1:1,000; Abcam) at 37°C for 15 minutes. The slides were further incubated with the streptavidin-biotin-peroxidase complex (ZSGB-BIO, Beijing, China). The slides were then washed with PBS and incubated with diaminobenzidine for 15 minutes. Finally, the slides were rinsed with distilled water and counterstained with hematoxylin, coverslipped, and examined. The slide of a diagnosed laryngeal squamous cell carcinoma was used as a positive control, and the slide processed with PBS in replacement of the primary antibody was used as a negative control.
Immunohistochemical Evaluation
Positive cells were defined using the following criteria: brown stain in the nucleus of epithelial cells is indicative for Ki-67 and cyclin D1 and in the cytoplasm of stromal cells for TAMs. Low-grade dysplasia, high-grade dysplasia, CIS, and normal mucosa epithelial were evaluated in five ×200 fields in four parts of epithelial areas-basal, parabasal, middle third, and upper third layers for Ki-67 and cyclin D1, and a mean value was calculated for each layer. Mean percentage of CD163+ TAMs infiltrating the epithelium relative to the total number (infiltrating the epithelium and stroma) of TAMs in different grades of laryngeal dysplasia was estimated.
Statistical Analysis
The differences among various grades of laryngeal dysplasia were analyzed using one-way analysis of variance. The sensitivity and specificity of biomarkers for the diagnosis of laryngeal dysplasia were analyzed using receiver operating characteristic (ROC) curves. A P value of less than .05 was considered statistically significant. All analyses were conducted using SPSS 20 (SPSS, Chicago, IL).
Results
In total, 133 paraffin-embedded specimens were analyzed, including low-grade laryngeal dysplasia (n = 31), high-grade laryngeal dysplasia (n = 49), CIS (n = 23), and 30 cases of normal mucosa. ❚Table 1❚ and ❚Table 2❚ show the mean values of CD163, Ki-67, and cyclin D1 in normal mucosa and laryngeal dysplasia.
Immunolocalization of CD163+ TAMs in Normal Mucosa, Laryngeal Dysplasia, and CIS
Mean percentages of CD163+ epithelium-infiltrating TAMs in high-grade laryngeal dysplasia, ❚Image 1I❚, ❚Image 1K❚, ❚Image 1M❚, and ❚Image 1O❚ and CIS ❚Image 1S❚ were significantly higher than those in low-grade laryngeal dysplasia ❚Image 1G❚ and normal mucosa ❚Image 1C❚ (❚Figure 1A❚, P = .000). Mean percentage of CD163+ epithelium-infiltrating TAMs increased with the development of the histopathologic grades ( Figure  1A , P < .05).
Immunolocalization of Ki-67 in Normal Mucosa, Laryngeal Dysplasia, and CIS
In the basal layer, the number of Ki-67+ cells was overexpressed in high-grade laryngeal dysplasia (67.20 cells/field; ❚Image 1J❚ and ❚Image 1N❚) and CIS (81.7 cells/ field; ❚Image 1Q❚ and ❚Image 1R❚), while Ki-67+ cells were rare in normal mucosa (13.67 cells/field; ❚Image 1A❚ and ❚Image 1B❚) and low-grade laryngeal dysplasia (18.32 cells/field; ❚Image 1E❚ and ❚Image 1F❚) (❚Figure 2A❚, P < .05). In normal mucosa, the number of Ki-67+ cells in the parabasal layer (45.23 cells/field) was higher than that in the basal layer (13.67 cells/field) (Figure 2A , P < .05), and similarly, in low-grade laryngeal dysplasia, the number of Ki-67+ cells in the parabasal layer (44.9 cells/field) was also significantly higher than that in the basal layer (18.32 cells/field) (Figure 2A , P < .05). In the middle third layer, the number of Ki-67+ cells was significantly higher in high-grade laryngeal dysplasia (27.56 cells/field) and CIS (36.0 cells/field) than in low-grade laryngeal dysplasia (21.13 cells/field) (❚Figure 2B❚, P < .05). In the upper third layer, the number of Ki-67+ cells was higher in CIS (23.04 cells/field; Image 1R) than in normal mucosa (0.0 ± 0.0 cells/field; Image 1B) and lowgrade laryngeal dysplasia (0.0 ± 0.0 cells/field; Image 1F) ( Figure 2B , P < .05).
Immunolocalization of Cyclin D1 in Normal Mucosa, Laryngeal Dysplasia, and CIS
The immunolocalization of cyclin D1 was consistent with the results of Ki-67+ cells in the basal layer, where cyclin D1 was overexpressed in highgrade laryngeal dysplasia (61.18 cells/field; ❚Image 1L❚ and ❚Image 1P❚) and CIS, but cyclin D1 was rare in normal mucosa (13.6 cells/field; ❚Image 1D❚) and lowgrade laryngeal dysplasia (15.26 cells/field; ❚Image 1H❚) (❚Figure 2C❚, P < .05). In normal mucosa, cyclin D1 expression in the parabasal layer (45.7 cells/field) was higher than that in the basal layer (13.6 cells/ field) ( Figure 2C , P < .05), and correspondingly, in low-grade laryngeal dysplasia, cyclin D1 expression in the parabasal layer (44.87 cells/field) was higher than Figure 2D , P < .05). However, cyclin D1 expression in the parabasal layer showed no difference between each lesion group ( Figure 2C ).
Immunolocalization of CD163+ TAMs and Ki-67 as Biomarkers to Differentiate Low-Grade Laryngeal Dysplasia and High-Grade Laryngeal Dysplasia
In high-grade dysplasia and CIS, because CD163+ epithelium-infiltrating TAMs were significantly increased and Ki-67+ cells were significantly higher in the basal layer, ROC curves were used to investigate the specificity and sensitivity of CD163+ TAMs and Ki-67 as potential biomarkers to help differentiate low-grade laryngeal dysplasia and high-grade laryngeal dysplasia and CIS. The areas under the curve were 0.958 for Ki-67 (P < .0001) and 0.909 for CD163+ TAMs (P < .0001). The results indicated that the percentage of CD163+ epithelium-infiltrating TAMs and the mean value of Ki-67 in the basal layer may be effective markers to distinguish low-grade laryngeal dysplasia from high-grade laryngeal dysplasia and CIS ❚Figure 3❚. Interestingly, the extent of CD163+ TAM infiltration in the epithelium was significantly correlated with the level of Ki-67 expression in the basal layer (❚Figure 1B❚, r = 0.784, P = .000).
Discussion
This report is about of the immunolocalization of CD163+ TAMs, Ki-67, and cyclin D1 under the new 2017 WHO classification system of laryngeal precursor lesions-a three-tiered classification: low-grade laryngeal dysplasia (including squamous hyperplasia and mild dysplasia), high-grade laryngeal dysplasia (including moderate dysplasia, severe dysplasia), and CIS, which is separate from high-grade laryngeal dysplasia. 6 Although the new classification system has better interobserver agreement, we also need feasible and reliable biomarkers to support the new classification system and predict the biological behavior of laryngeal dysplasia for treatment. Research has been focusing on the relationship between TAMs and laryngeal squamous cell carcinoma, not laryngeal precursor lesions, and it has found that high-density
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❚Figure 1❚ Semiquantitative evaluation of CD163+ tumor-associated macrophage (TAM) density and the relationship between CD163+ TAM density and Ki-67+ epithelium in human larynx tissue. A, CD163+TAM density in the normal mucosa (NM) (n = 30), low-grade dysplasia (LGD) (n = 31), high-grade dysplasia (HGD) (n = 49), and carcinoma in situ (CIS) (n = 23). Mean percentages of CD163+ epithelium-infiltrating TAMs in HGD and CIS were significantly higher than those in LGD and NM. Mean percentage of CD163+ epithelium-infiltrating TAMs increased with the LGD-HGD-CIS sequence. Data represent mean ± SD in five ×200 fields (*P < .05, **P = .000). B, The mean percentage of CD163+ TAM infiltration in the epithelium had a significant positive correlation with the level of Ki-67 expression in the basal layer (P = 0.000, r = 0.784).
TAMs were associated with metastasis and poor prognosis of patients with laryngeal squamous cell carcinoma. 10 However, the diagnostic value of CD163+ TAMs during the occurrence and progression of laryngeal precursor lesions remains unknown. In the present study, in contrast to methods used in other studies (counting the total number of peritumoral and intratumoral CD163+ TAMs), we studied the ratio of the number of CD163+ A, In the basal layer, Ki-67+ cells were overexpressed in HGD and CIS, while Ki-67+ cells were rare in NM and LGD; in NM, Ki-67+ cells in the parabasal layer were higher than those in the basal layer, and similarly, in LGD, Ki-67+ cells in the parabasal layer were also significantly higher than those in the basal layer. B, In the middle third layer, Ki-67+ cells were significantly higher in HGD and CIS than in LGD. In the upper third layer, Ki-67+ cells were higher in CIS than in NM and LGD. C, In the basal layer and parabasal layer, the immunolocalization of cyclin D1 was consistent with the results of Ki-67+ cells. D, In the middle third layer, cyclin D1 expression was significantly higher in CIS than in LGD and NM. In the upper third layer, the colocalization of cyclin D1 and Ki-67 was also observed. Data represent mean ± SD in five ×200 fields (*P < .05).
epithelium-infiltrating TAMs relative to the total number (infiltrating the epithelium and stroma) of CD163+ TAMs, which is more easily observed and precise for the diagnosis of laryngeal dysplasia. Therefore, mean percentages of CD163+ epithelium-infiltrating TAMs were significantly higher in high-grade laryngeal dysplasia than in low-grade laryngeal dysplasia. Many researchers have found that the increase in the rate of CD163+ TAM infiltration was associated with the progression of precancerous lesions. 12, 15 In contrast, the increased CD163+ macrophages infiltration possessed M1 phenotype was observed in mild and moderate epithelial dysplasia, not severe epithelial dysplasia, of oral premalignant lesion dysplasia. 11 It is likely that the infiltrated TAMs in human solid tumors appear to consist of a heterogeneous population, and M1 phenotype macrophages may also coexpress CD163+ M2 makers. 11, 16, 17 In addition, mean percentages of CD163+ epithelium-infiltrating TAMs were significantly higher in CIS than in high-grade laryngeal dysplasia, and in comparison to other lesion types, the mean percentage of CD163+ epithelium-infiltrating TAMs was highest in CIS. These results suggest that the most severe precancerous step in the larynx epithelium is CIS and that the percentage of CD163+ epithelium-infiltrating TAMs may serve as a molecular marker for severe histopathologic changes, following the high risk of malignant transformation. CD163+ TAM ROC curve analysis results indicate that CD163+ epithelium-infiltrating TAMs may serve as a biomarker for assisting histopathologic classification of laryngeal precursor lesions, especially for differentiating low-grade from high-grade dysplasia lesions.
The present study investigated the immunolocalization of Ki-67 and cyclin D1+ cells, which were rare in the basal layer and high in the parabasal layer in normal mucosa and low-grade laryngeal dysplasia. Some studies showed that in the healthy lip epithelia, cyclin D1 and Ki-67 expressions were low in basal layers and high in parabasal layers, suggesting a pattern of physiologic asymmetrical proliferation.
14 Correspondingly, in lowgrade laryngeal dysplasia, Ki-67+ and cyclin D1+ cell immunolocalization also showed a pattern of physiologic asymmetrical proliferation. The previous report indicates that basal layer stem cells (SCs) support epithelium renewal. 18 However, amplifying transitory cells increase the number of differentiated cells coming from the slow single division of SCs. 18 This asymmetrical division may lead to oncogenic protection in normal mucosa. 18 We assume there may be oncogenic protection in low-grade laryngeal dysplasia, because low-grade laryngeal dysplasia also shows a pattern of physiologic asymmetrical proliferation. The present results may provide further evidence to demonstrate that low-grade laryngeal dysplasia (mild dysplasia) cannot be viewed as a precancerous lesion of the larynx 5 and may partially explain the reason for a significant difference in the risk of progression to laryngeal squamous cell carcinoma between low-grade laryngeal dysplasia and high-grade laryngeal dysplasia. 5, 6 When laryngeal dysplasia progressed to high-grade laryngeal dysplasia or even CIS, we found higher Ki-67 and cyclin D1 expression in the basal layer, in comparison to the normal mucosa. The once asymmetrical proliferative pattern disappears, and at the same time, a symmetric proliferative pattern is developed. According to the previous study, 18 we assume that SCs undergo malignant transformation in high-grade laryngeal dysplasia and CIS, showing the increase of Ki-67 and cyclin D1 expression in the basal layer. SCs play a dominant role in the malignant transformation. Due to the long life span of SCs in epithelia, they cumulate oncogenic alterations that produce the symmetric proliferative pattern, producing two genetically unstable daughter SCs that accumulate large quantities of oncogenic events needed to develop malignant clones throughout the basal layer.
14 Furthermore, in accordance with Ki-67 ROC curve analysis results, our study suggests that the symmetric proliferative pattern of Ki-67 is common and has high specificity and sensitivity to differentiate low-grade dysplasia and high-grade dysplasia of the larynx. For example, in a case with substantial divergence between low-grade dysplasia (mild dysplasia) and high-grade dysplasia (moderate dysplasia), the pathologist could apply Ki-67 immunolocalization for auxiliary diagnosis. An increase of Ki-67 in the parabasal layer could enhance the pathologist's confidence in a lowgrade dysplasia (mild dysplasia) diagnosis, and conversely an increase of Ki-67 in the basal layer suggests a highgrade dysplasia (moderate dysplasia) diagnosis. In addition, in the upper third layer, Ki-67 and cyclin D1 were significantly higher in CIS than in high-grade laryngeal dysplasia, in accordance with our result of CD163+ epithelium-infiltrating TAMs in CIS. Ki-67 and cyclin D1 are associated with an early change in premalignant epithelia, 13, 14 and some studies have indicated that Ki-67 expression increases with the severity of dysplastic changes in the laryngeal epithelium, 19, 20 suggesting that the most severe precancerous step in the larynx epithelium is CIS. The results support the three-tiered classification, which could facilitate clinical decisions about treatment strategies for patients with high-grade laryngeal dysplasia and CIS.
Interestingly, the mean percentage of CD163+ epithelium-infiltrating TAMs was correlated with Ki-67 expression in the basal layer. More evidence has demonstrated that the interaction between tumor and stromal cells (crosstalk) plays an important role in the occurrence and evolution of the tumor, especially in tumor-infiltrating immune cells. 21, 22 Our study found that CD163+ TAMs are recruited to form the tumorigenic microenvironment. Large transforming growth factor (TGF)-β secreted by TAMs promotes cell proliferation and Ki-67 overexpression in the tumor border region.
23,24 Therefore, we speculate that SCs, after accumulating oncogenic alterations, can attract CD163+ TAMs to secret TGF-β and promote the progression of laryngeal dysplasia. At the same time, CD163+TAMs pass the basement membrane and infiltrate the epithelium. This hypothesis needs further studies to confirm.
Conclusion
Our results showed that the percentage of CD163+ epithelium-infiltrating TAMs and the mean value of Ki-67 in the basal layer may be used as diagnostic biomarkers to differentiate low-grade dysplasia and high-grade dysplasia of the larynx, indirectly supporting the application of the new classification system. A symmetric proliferative pattern is developed during the process of laryngeal carcinogenesis following Ki-67 overexpression.
